[SLN] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Sep-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -38.51%
YoY- -16.95%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 3,371 3,156 1,988 122 0 0 385 43.54%
PBT -9,326 -12,052 -9,540 -6,636 -5,370 1,441 -2,410 25.28%
Tax -2,223 -2,123 -462 950 507 508 557 -
NP -7,103 -9,929 -9,078 -5,686 -4,862 1,949 -1,854 25.07%
Tax Rate - - - - - -35.30% - -
Total Cost 10,474 13,085 11,066 5,808 4,862 -1,949 2,239 29.30%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -210.71 -314.61 -456.64 -4,660.66 0.00 0.00 -481.43 -12.85%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.22 -0.33 -0.33 -0.22 -0.21 0.08 -0.08 18.35%
EPS Diluted -0.22 -0.33 -0.33 -0.22 -0.21 0.08 -0.08 18.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.